Preview

Drug development & registration

Advanced search

EMBININ IS A PERSPECTIVE CARDIOTONIC MEAN FOR NATURAL ORIGIN

Abstract

Embinin is a flavone C-glycoside from the aerial part of the milky white tangent (Iris lactea). Cardiotonic action was established earlier for the extract of Iris lactea. Identification of the active substance responsible for this type of biological activity seems to be an urgent task. The purpose of this study was to evaluate the cardiotropic effect and the toxicological profile of embinin. The acute toxicity of embinin was determined in accordance with GOST 32644-2014, the inotropic effect of embinin was evaluated in comparison with digoxin in the model of perfusion of the isolated rat heart by Langendorf, and also in vivo by echocardiographic study with calculation of the left ventricular shortening fraction and electrocardiogram analysis. The embinin in a dose of 2000 mg/kg didn’t cause the death of female rats. The substance has a pronounced inotropic effect. Establishment of a pronounced cardiotonic effect in the experiment and low toxicity, as well as a high probability of the presence of cardioprotective action of embinin, predicted using the PASS program, allow us to consider embinin as a promising molecule for further studies in cardiovascular disease.

About the Authors

D. Yu. Ivkin
Saint-Petersburg State Chemical and Pharmaceutical University
Russian Federation


V. G. Luzhanin
Saint-Petersburg State Chemical and Pharmaceutical University
Russian Federation


A. A. Karpov
Academician I. P. Pavlov First St. Petersburg State Medical University; National Medical Research Center
Russian Federation


S. M. Minasyan
Academician I. P. Pavlov First St. Petersburg State Medical University; National Medical Research Center
Russian Federation


Ya. I. Poleshchenko
Academician I. P. Pavlov First St. Petersburg State Medical University
Russian Federation


A. E. Mamedov
Academician I. P. Pavlov First St. Petersburg State Medical University
Russian Federation


M. N. Povydysh
Saint-Petersburg State Chemical and Pharmaceutical University
Russian Federation


V. V. Poroykov
Institute of Biomedical Chemistry
Russian Federation


I. A. Narkevich
Saint-Petersburg State Chemical and Pharmaceutical University
Russian Federation


References

1. Yakovlev G. P. The encyclopedic dictionary of medicinal plants. 3rd ed. - SPb., Spetslit, 2015. 759 p.

2. Melnikova T. I. The pharmacological research of the summary extract of Iris lacteal. Dissertation of the PhD at biological sciences. - Spb., 1994. 162 p.

3. Friedman F. K., West D., Sugimura T., Gelboin H. V. Flavone modulators of rat hepatic aryl hydrocarbon hydroxylase // Pharmacology. 1985. № 31. Is. 4. P. 203-2076.

4. Lanina N. E. The creation of tincture technology from the grass of Iris lacteal: the author's abstract of the dissertation of the PhD at biologi-cal sciences. - Spb., 2003. 23 p.

5. Tixomirova L. I., Bazarnova N. G., Mikushina I. V., Dolganova Z. B. Pharmacological and biochemical basis for the use of some species from the genus Iris L. (rewiev) // Chemistry of plant raw materials. 20015. № 3. P. 25-34.

6. Pryaxina N. I. Phytochemical analysis of Iris lacteal. Dissertation of the PhD at pharmaceutical sciences. - Spb., 1984. 193 p.

7. Luzhanin V. G., Whaley А. К. Development of embinin isolation technology from Iris lactaea and the research of its pharmacological activity // Reviews of clinical pharmacology and drug therapy. 2016. № 14. Р. 42.

8. Whaley A. K., Ebrahim W., El-Neketi M., Ancheeva E. U., Ferhat Can Özkaya, Pryakhina N. I., Sipkina N. U., Luzhanin V.G., Liu Zhen, Peter Proksch. New acetylated flavone C-glycosides from Iris lactea // Tetrahedron Letters. 2017. V 58. Is. 22(31). P. 2171-2173.

9. Filimonov D. A., Lagunin A. A., Gloriozova T. A., Rudik A. V., Druzhilovskiy D. S., Pogodin P. V., Poroikov V. V. Prediction of the biological activity spectra of organic compounds using the PASS online web resource // Chemistry of Heterocyclic Compounds. 2014. № 50(3). Р. 444-457.

10. Druzhilovskiy D. S., Rudik A. V., Filimonov D. A., Lagunin A. A., Gloriozova T. A., Poroikov V.V. Online resources for the prediction of biological activity of organic compounds // Russian Chemical Bulletin, International Edition. 2016. № 65(2). Р. 384-393.

11. Murtazalieva K. A., Druzhilovskiy D. S., Goel R. K., Sastry G. N., Poroikov V. V. How good are publicly available web services that predict bioactivity profiles for drug repurposing? // SAR and QSAR in Environmental Research. 2017. № 28(10). Р. 843-862.

12. Opi L.C. Medicines in the practice of a cardiologist. - M.: Rid Elsiver, 2010. P. 255-312.

13. Mashkovski M.D. Medicines. 15th ed. - M.: Novaya Volna, 2005. 1200 p.

14. GOST 32644-2014. Methods for the testing of chemical products on the human organism. Acute oral toxicity - methods of class discription.

15. Minasyan S. M., Galagudza M. M., Sinin D. L., Bobrova E. A., Zverev D. A., Korolev D. V., Dmitriev U. V., Vasil’eva M. C., Grigorova U. N., Vlasov T. D. Methodology of isolated rat heart perfusion // Regional blood circulation and microcirculation. 2009. T. 8. № 4(32). P. 54-59.

16. Karpov A. A., Ivkin D. U., Dracheva A. V., Pituchina N. N. i dr. Modeling of postinfarct heart deficiency using left coronary artery occlusion // Biomedicine. 2014. № 3. P. 32-48.

17. Lagunin A., Zakharov A., Filimonov D., Poroikov V. QSAR modelling of rat acute toxicity on the basis of PASS Prediction // Molecular Informatics. 2011. № 30(2-3). Р. 241-250.

18. Weinhouse E, Kaplanski J, Warszawski D, Danon A, Gorodischer R. Cardiac toxicity of digoxin in newborn and adult rats // Pediatr Pharmacol (New York). 1980. № 1(2). Р. 97-103.


Review

For citations:


Ivkin D.Yu., Luzhanin V.G., Karpov A.A., Minasyan S.M., Poleshchenko Ya.I., Mamedov A.E., Povydysh M.N., Poroykov V.V., Narkevich I.A. EMBININ IS A PERSPECTIVE CARDIOTONIC MEAN FOR NATURAL ORIGIN. Drug development & registration. 2018;(3):166-170. (In Russ.)

Views: 795


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2305-2066 (Print)
ISSN 2658-5049 (Online)